Related Experiment Videos
[Clinical experience with cefoxitin in the surgical field]
The Japanese Journal of Antibiotics
|January 1, 1984
Summary
Cefoxitin (CFX) demonstrated high efficacy in surgical patients. This antibiotic proved highly effective for treating surgical infections and preventing postoperative complications with minimal side effects.
Area of Science:
- Surgical Infectious Diseases
- Clinical Pharmacology
- Antibiotic Efficacy
Background:
- Cefoxitin (CFX) is an antibiotic used in surgical settings.
- Evaluating CFX for treating surgical infections and preventing postoperative complications is crucial.
Observation:
- CFX was administered to 49 hospitalized patients in a surgical field.
- 12 patients received CFX for existing surgical infections.
- 37 patients received CFX for prophylaxis against postoperative infections.
Findings:
- For surgical infections, CFX showed a 91.7% efficacy rate (1 excellent, 10 good, 1 poor).
- For postoperative infection prophylaxis, CFX also achieved a 91.7% clinical efficacy rate.
- Only one patient experienced a mild eruption, indicating a favorable safety profile.
Implications:
- Cefoxitin is highly effective for treating surgical infections.
- Cefoxitin serves as a valuable prophylactic agent in surgical procedures.
- The study supports the utility of CFX in the surgical field due to its efficacy and safety.